• 4-year results of contiguous cervical arthroplasty versus anterior discectomy and fusion

    Further follow-up was recently reported from a prospective multicenter randomized controlled, non-inferiority IDE trial comparing 2-level cervical total disc replacement (TDR) using the Mobi-C artificial disc versus fusion for symptomatic two-level radiculopathy or myeloradiculopathy. 12.8% of patients were lost to follow-up at 48 months. Statistical superiority was maintained for the 2-level TDR group using a composite clinical/radiologic primary endpoint measure of “overall success” that includes the NDI success rate (79.3% versus 53.4%, p < 0.0001) and the need for secondary surgeries (4.0% versus 15.2%, p < 0.0001). Statistically less radiologic adjacent segment pathology was also maintained at 48 months. This ongoing FDA-regulated study continues to present intriguing results that further highlight need for extended follow-up to address TDR-specific concerns regarding heterotopic ossification and disc height loss.


    National Center for Biotechnology Information

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site here. Privacy Policy